Select Category

FDA approves first use of Tracer-QC at the Gordon Center


Radiopharmaceutical company Trace-Ability, Inc. announced that the FDA has approved the first use of its solution, Tracer-QC, for release testing Ammonia N-13 Injection at the MGH Gordon Center PET Core. Tracer-QC automates the positron emission tomography (PET) tracer release testing process, which the company says is known for its complexity. “Despite the clear value of ...

Rethinking Convolutional Neural Networks (CNNs)


Dr. C.-C. Jay Kuo is a University of Southern California Distinguish Professor and Directory of its Media Communications Laboratory. Dr. Kuo received his Ph.D. from MIT in 1987. He has served as editor for 12 international journals and co-authored around 250 journal papers, 900 conference papers and 14 books. He was the guest speaker at ...


Three Research Fellows promoted to Instructor


We are please to announce that three Research Fellows in the Gordon Center have been promoted to the title of Instructor. Congratulations to Kai Bao, Fangxu Xing, and Gengyang Yuan!...

Novel PET Imaging Tracer May Improve Monitoring of Multiple Sclerosis


In a recent paper published by the journal Scientific Reports, Dr. Pedro Brugarolas and his colleagues describe the development and testing in animal models of a new PET tracer for demyelination. Their new tracer is based on the MS drug 4-aminopyridine (4AP, dalfampridine) which binds to potassium channels in demyelinated axons allowing the visualization of demyelinated lesions in animal models of MS noninvasively....

Study Reveals Association between Aβ, Tau, Circuitry and Cognition


Dr. Heidi Jacobs along with Dr. Keith Johnson have published a paper in Nature Neuroscience entitled "Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals". ...


Research Agreement Signed with Cerveau Technologies


Cerveau Technologies Inc. signed an agreement with the MGH Gordon Center to support multiple projects over the next several years. These research projects are for studies of an early stage imaging agent (MK-6240) to be used in Positron Emission Tomography (PET) scans for assessing the status and progression of neurofibrillary tangles (NFTs) in the brain. NFTs made up of aggregated tau protein are a hallmark of several neurodegenerative diseases, including Alzheimer’s disease....

Keith Johnson Named 2017 Clarivate Analytics Highly Cited Researcher


Dr. Keith Johnson has been named to the 2017 “Highly Cited Researchers” list from Clarivate Analytics. The list recognized 3,538 highly cited researchers in 21 fields of the sciences and social sciences. These researchers have distinguished themselves by publishing a high number of papers that rank in the top one percent most-cited in their respective fields internationally over a recent 11-year period....

2018 Gordon Center Winter Holiday Party


A warm thank you to everyone who joined us for our winter holiday party....

2018 Human Amyloid Imaging Conference


The 12th Human Amyloid Imaging Conference will take place in Miami, Florida on January 17-19, 2018. Dr. Keith Johnson is organizing the event with the help of co-organizers Dr. Bill Klunk (University of Pittsburgh), Dr. Chet Mathis (University of Pittsburgh) and Dr. Bill Jagust (University of California, Berkeley). The conference includes podium and poster presentations on cutting edge research into biomarkers for Alzheimer’s-related disease....

Senior Research Technologist Honored by Coast Guard


Congratulations to Julia Scotton, Senior Research Technologist and Radiation Safety Manager at the MGH Gordon Center, for her recent promotion to Chief Petty Officer in the U.S. Coast Guard. ...